Key Points:

This is a joint position of the American Heart Association (AHA) and the American Diabetic Association (ADA) on the management of cardiovascular disease (CVD) in type 2 diabetic patients. Based on new clinical trial evidence and the addition of HbA1c to the diabetes diagnostic criteria since the publication of the 2007 guidelines, these groups came together again in 2015 to release an updated statement.

Why is this Relevant?

  • Diabetes is a major risk factor for CVD, and CVD is the most common cause of death among adults with diabetes. The management of CVD risk is critical for the diabetic patient
  • This position points to lifestyle management including nutrition and physical activity as a corner-stone in the clinical care for individuals with diabetes, helping to attain individualized glycemic, lipid and blood pressure goals, achieve and maintain and healthy body weight, prevent or delay CVD complications, and provide those living with diabetes with tools for meal planning
  • The position discusses the use of additional treatment modalities including pharmacotherapy and metabolic surgery in the management of CVD risk in this patient population

Reference:

Download PDF

Share this:

Resources from our research partners and collaborations

Sign up for the MHICN Newsletter

Your Weekly Nutrition Bulletin features the latest content on topics spanning our therapeutic platforms from MHICN research staff and clinical partners. Receive videos, clinical modules, research reviews and more by email each week. Sign up here or view previous weeks' newsletters.

Subscribe View Newsletter Archives

Continuing Education

MHICN has partnered with leaders in preventive medicine, integrative medicine, and medical education to provide cutting-edge education for providers of all backgrounds with an interest in functional and lifestyle medicine. We are excited to share these free educational modules featuring podcasts, videos, and print articles.

Learn More